Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE012 (BRA) (Dr. Kowalski)
· consented 2023-03-02
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2023-05-09 (study day 53); relationship: not assessed
moderate
assessed
2026-08-18
Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2023-12-20 (study day 278); relationship: not assessed
severe
assessed
2026-08-18
Grade 3 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-12-23 (study day 281); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2024-03-29 (study day 378); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2024-08-03 (study day 505); relationship: N
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.